Tanshinone I suppresses hepatocellular carcinoma cells growth through targeting DNA double-strand break repair

Hepatocellular carcinoma (HCC) is one of the most common types of malignant tumors with increasing incidence rates and high mortality rates. The currently available methods for treating HCC include surgery, radiotherapy or chemotherapy, but all of them have limitations. Therefore, developing novel t...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Zhen, Feng, Nannan, Geng, Anke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324423/
https://www.ncbi.nlm.nih.gov/pubmed/37408176
http://dx.doi.org/10.1080/15384047.2023.2229958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324423/
https://www.ncbi.nlm.nih.gov/pubmed/37408176
http://dx.doi.org/10.1080/15384047.2023.2229958

Ejemplares similares